2 terminated, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Bacterial Pneumonia: new trials by email Literature Review of Bacterial Pneumonia trials Research Report on Bacterial Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CMTX-101 CMTX-101, Placebo - Community-acquired Pneumonia, Bacterial Pneumonia | Phase 1 | Terminated | Clarametyx Biosciences, Inc. | 28 | 2022-11-14 | 2024-10-21 |
| Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia Cefiderocol, Standard of Care Antibiotic - Bacterial Pneumonia | Phase 1 | Terminated | Shionogi | 7 | 2019-02-20 | 2020-11-05 |
| Cx611-0204 SEPCELL Study Cx611, Placebo - Bacterial Pneumonia | Phase 1 / Phase 2 | Completed | Tigenix S.A.U. | 84 | 2017-01-30 | 2022-04-06 |
Pneumonia, Bacterial (3) · Community-Acquired Pneumonia (1)
Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Infections (3) · Lung Diseases (3) · Pneumonia (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Community-Acquired Infections (1)
Cefiderocol (1)
Clarametyx Biosciences, Inc. (1) · Shionogi (1) · Tigenix S.A.U. (1)
United States (2) · Belgium (1) · France (1) · Italy (1) · Lithuania (1) · Norway (1) · Spain (1)
2015 (1)